https://www.ndtv.com/health/fathers-exposure-to-microplastics-may-increase-metabolic-dysfunction-and-diabetes-risk-in-daughters-finds-study-10031924
A fathers exposure to microplastics can trigger metabolic dysfunctions in children, with daughters more at risk of developing diabetes, according to animal...
metabolic dysfunctionfatherexposuremicroplasticsmay
https://www.pharmaceutical-technology.com/data-insights/pegargiminase-polaris-pharmaceuticals-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/
Pegargiminase is under clinical development by Polaris Pharmaceuticals and currently in Phase II for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
metabolic dysfunctionpegargiminasepolarispharmaceuticalsassociated
https://www.everydayhealth.com/liver-disease/metabolic-dysfunction-associated-steatohepatitis/guide/
Sep 12, 2025 - MASH is a progressive form of liver disease that occurs when there’s an accumulation of fat in the liver. Learn more about risk factors, symptoms, and...
metabolic dysfunctionassociatedsteatohepatitismashsymptoms
https://www.pharmaceutical-technology.com/data-insights/da-1241-neurobo-pharmaceuticals-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/
DA-1241 is under clinical development by NeuroBo Pharmaceuticals and currently in Phase II for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
metabolic dysfunctiondapharmaceuticalsassociatedsteatohepatitis
https://pubmed.ncbi.nlm.nih.gov/40310463/
Metabolic dysfunction-associated steatohepatitis (MASH) represents a progressive form of steatotic liver disease which increases the risk for fibrosis and...
lipid dropletlivercholesterolcontentkey
https://www.pharmaceutical-technology.com/data-insights/survodutide-boehringer-ingelheim-international-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/
Survodutide is under clinical development by Boehringer Ingelheim International and currently in Phase III for Metabolic Dysfunction-Associated Steatohepatitis...
boehringer ingelheimmetabolic dysfunctionsurvodutideinternationalassociated
https://liverfoundation.org/liver-diseases/veterans-information-center/metabolic-dysfunction-associated-steatotic-liver-disease-masld-and-liver-health-for-veterans/
Dec 1, 2025 - Metabolic dysfunction–associated steatotic liver disease (MASLD) is a liver condition characterized by fat accumulation in the liver linked to metabolic risk...
steatotic liver diseasemetabolic dysfunctionassociatedmasldhealth
https://pubmed.ncbi.nlm.nih.gov/40128809/
Parkinson's disease (PD) is a multi-system disorder characterized histopathologically by degeneration of dopaminergic neurons in the substantia nigra pars...
immune cellmetabolic dysfunctionparkinsondisease
https://elifesciences.org/articles/29968
Store operated calcium entry is defective in hepatocytes of obese mice, and restoring this process is sufficient to improve glucose metabolism.
defectivestimmediatedstoreoperated
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=40186&ver=8&stateRegion=all&contractorNumber=all&proposedStatus=C&sortBy=commentStart&bc=11
Use this page to view details for the Local Coverage Determination for MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated...
biomarker testingrisk stratificationproposedlcdmetabolic
https://www.uea.ac.uk/course/phd-doctorate/phd-the-role-of-bilophila-wadsworthia-in-microbiome-driven-metabolic-dysfunction-impact-of-obesity-associated-microbiomes-narbadq25mmb
PhD The Role of Bilophila wadsworthia in Microbiome-Driven Metabolic Dysfunction: Impact of Obesity-Associated Microbiomes (NARBAD_Q25MMB) 2025/26 | UEA
bilophila wadsworthiaphdrolemicrobiomedriven
https://www.pharmaceutical-technology.com/data-insights/azemiglitazone-cirius-therapeutics-metabolic-dysfunction-associated-steatohepatitis-mash-likelihood-of-approval/
Azemiglitazone is under clinical development by Cirius Therapeutics and currently in Phase II for Metabolic Dysfunction-Associated Steatohepatitis (MASH).
metabolic dysfunctionazemiglitazoneciriustherapeuticsassociated